Many abnormally methylated genes have been reported in ALL, for example, CDKN2B promoter methylation has been repeatedly described in ALL leading to claims that this methylation is involved in leukaemogenesis [10]. The gene discussed is CDKN2B; the disease is acute lymphoblastic leukemia.